MariMed CEO Jon R. Levine converts 75,000 stock awards

Q: How many MRMD RSUs did Jon R. Levine convert?

Jon R. Levine converted 75,000 RSUs into common stock on November 7, 2026, at one share per RSU. The RSUs were granted on November 7, 2023, and no RSUs remained under that grant after the transaction.

Q: How many MRMD shares were withheld for Jon R. Levine’s RSU taxes?

The issuer withheld 22,013 shares to satisfy tax withholding obligations connected with vesting the RSUs. The reported transaction price was $0.067 per share.

The RSUs came from a November 7, 2023 grant, while the issuer withheld common shares for tax obligations at vesting.

Available on EDGAR 11/09/2026 - 04:10 PM EST Accepted by SEC EDGAR 11/09/2026 - 04:09 PM EST

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

MARIMED INC. President and CEO Jon R. Levine, listed as a director and ten percent owner, converted 75,000 restricted stock units into common stock on November 7, 2026, on a one-for-one basis. The issuer withheld 22,013 shares for tax withholding obligations related to the RSU vesting; the reported transaction price was $0.067 per share. The grant, made on November 7, 2023, has no remaining RSUs. A separate holding entry lists 6,684,640 shares held by Levine’s spouse; Levine disclaims beneficial ownership of those shares.

Insider Trade Summary

75,000 shares exercised/converted

Exercise 3 txns

Insider Levine Jon R

Role President and CEO

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units (RSU) ^{F1, F4}	75,000	$0.00	$0.00
Exercise	Common stock ^F1	75,000	$0.00	$0.00
Tax Withholding	Common stock ^F2	22,013	$0.067	$1K
Holding	Common stock ^F3	--	--	--

Holdings After Transaction: Restricted Stock Units (RSU) — 0 units (Direct); Common stock — 21,440,780 shares (Direct); Common stock — 6,684,640 shares (Indirect, By Spouse)

Footnotes (4)

F1. RSUs convert to shares of common stock on a one-for-one basis.
F2. Reflects shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of RSUs.
F3. These shares are held by the Reporting Person's spouse. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F4. The RSUs were granted on November 7, 2023; there are no remaining RSUs under this grant in accordance with the terms of an award agreement between the Issuer and the Reporting Person.

Key Figures

RSUs converted: 75,000 RSUs Conversion ratio: 1 common share per RSU Shares withheld: 22,013 shares +3 more

6 metrics

RSUs converted 75,000 RSUs Converted into common stock on November 7, 2026

Conversion ratio 1 common share per RSU RSUs convert to common stock on a one-for-one basis

Shares withheld 22,013 shares Withheld by the issuer for tax withholding obligations related to RSU vesting

Reported transaction price $0.067 per share Shares withheld in connection with RSU vesting

Remaining RSUs under grant 0 RSUs Grant dated November 7, 2023

Shares held by spouse 6,684,640 shares Levine disclaims beneficial ownership of the spouse-held shares

Key Terms

Restricted Stock Units (RSU), tax withholding obligations, beneficial ownership

3 terms

Restricted Stock Units (RSU) technical

"RSUs convert to shares of common stock on a one-for-one basis."

tax withholding obligations financial

"withheld by the Issuer to satisfy tax withholding obligations"

beneficial ownership regulatory

"disclaims beneficial ownership of these securities"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many MRMD RSUs did Jon R. Levine convert?

Jon R. Levine converted 75,000 RSUs into common stock on November 7, 2026, at one share per RSU. The RSUs were granted on November 7, 2023, and no RSUs remained under that grant after the transaction.

How many MRMD shares were withheld for Jon R. Levine’s RSU taxes?

The issuer withheld 22,013 shares to satisfy tax withholding obligations connected with vesting the RSUs. The reported transaction price was $0.067 per share.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Levine Jon R

(Last)

(First)

(Middle)

C/O MARIMED INC.

10 OCEANA WAY

(Street)

NORWOOD,

MASSACHUSETTS

02062

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MARIMED INC. [ MRMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
11/07/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common stock	11/07/2026		M		75,000	A	$0⁽¹⁾	21,462,793	D
Common stock	11/07/2026		F		22,013⁽²⁾	D	$0.067	21,440,780	D
Common stock								6,684,640	I	By Spouse⁽³⁾

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units (RSU)	⁽¹⁾	11/07/2026		M			75,000	⁽⁴⁾	⁽⁴⁾	Common Stock, par value $.001 per share	75,000	$0	0	D

Explanation of Responses:

1. RSUs convert to shares of common stock on a one-for-one basis.

2. Reflects shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of RSUs.

3. These shares are held by the Reporting Person's spouse. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

4. The RSUs were granted on November 7, 2023; there are no remaining RSUs under this grant in accordance with the terms of an award agreement between the Issuer and the Reporting Person.

Remarks:

	/s/ Jon R. Levine	11/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR